Historique de carrière de Charles Conway
Anciens postes connus de Charles Conway
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Director/Board Member | - | 03/10/2022 |
| Chief Tech/Sci/R&D Officer | 01/01/2017 | 03/10/2022 | |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/01/2000 | 01/01/2017 |
Formation de Charles Conway
| University of Central Missouri | Undergraduate Degree |
| University of California San Diego | Graduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Graduate Degree | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
- Bourse
- Insiders
- Charles Conway
- Expérience
